145 related articles for article (PubMed ID: 4150018)
1. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
Robak J; Grodzińska L
Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
[No Abstract] [Full Text] [Related]
2. [Inhibition of adrenergic beta receptors by N,N'-bis-[3-(2'ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine (Falirytmin) as compared to propranolol].
Mentz P; Bayer BL; Wartner U; Terhaag B; Förster W
Pharmazie; 1976; 31(9):640-2. PubMed ID: 14343
[No Abstract] [Full Text] [Related]
3. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
4. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
Johansson B
Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
[No Abstract] [Full Text] [Related]
5. Synthesis and pharmacological activity of 1-isopropylamino-3-(1-naphthylamino)-2-propanol, an analogue of propranolol.
Daniewski W; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):23-8. PubMed ID: 4775863
[No Abstract] [Full Text] [Related]
6. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
[No Abstract] [Full Text] [Related]
7. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
[No Abstract] [Full Text] [Related]
8. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
Coleman AJ; Leary WP; Asmal AC
Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
[No Abstract] [Full Text] [Related]
9. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
Femmer K
Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
[No Abstract] [Full Text] [Related]
10. Analysis of the effects of some derivatives of ethylenediamine on the cardiovascular system. Effect on adrenaline-induced arrhythmia.
Filczewski M
Acta Physiol Pol; 1974; 25(6):589-97. PubMed ID: 4456972
[No Abstract] [Full Text] [Related]
11. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
Mylecharane EJ; Raper C
Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
[No Abstract] [Full Text] [Related]
12. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
Bartsch W; Dietmann K; Leinert H; Sponer G
Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats.
Nowicka A; Prussak T; Szukalski B
Pol J Pharmacol Pharm; 1975; 27(2):113-20. PubMed ID: 168561
[TBL] [Abstract][Full Text] [Related]
14. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
Zakhari S
Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
[No Abstract] [Full Text] [Related]
15. Analysis of the effects of some derivatives of ethylenediamine on the cardiovascular system. The effect on blood supply and oxygen metabolism of the heart.
Filczewski M
Acta Physiol Pol; 1974; 25(6):577-88. PubMed ID: 4456971
[No Abstract] [Full Text] [Related]
16. [Evaluation of beta-adrenolytic activity. Structure-activity relationship].
Labrid C
Ann Med Interne (Paris); 1987; 138 Suppl 1():5-10. PubMed ID: 2884916
[No Abstract] [Full Text] [Related]
17. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
[No Abstract] [Full Text] [Related]
18. [Analysis of pharmacological properties of various potential beta adrenolytics of the aryloxypropanolamine type].
Béderová E; Edelsteinová S; Racanský V; Svec P
Cesk Farm; 1982 Sep; 31(7):279-85. PubMed ID: 6128077
[No Abstract] [Full Text] [Related]
19. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
Marchetti G; Merlo L; Noseda V
Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
[No Abstract] [Full Text] [Related]
20. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
